JB/CALL/POLE GROU/24/0.1/20.09.24 | Market Closed - Swiss Exchange 16:20:00 05/07/2024 BST | ||
| 0.85 CHF | +6.25% |
|
| Current month | +25.00% | ||
| 1 month | -15.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 0.85 | +6.25% |
| 04/07/24 | 0.8 | +9.59% |
| 03/07/24 | 0.73 | +7.35% |
| 28/06/24 | 0.68 | -8.11% |
| 27/06/24 | 0.74 | +1.37% |
Delayed Quote Swiss Exchange
Last update July 05, 2024 at 04:20 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPZZJB | |
| ISIN | CH1280666244 |
| Date issued | 14/08/2023 |
| Strike | 24 CHF |
| Maturity | 20/09/2024 (76 Days) |
| Parity | 10 : 1 |
| Emission price | 0.6 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 1.13 CHF |
|---|---|
| Lowest since issue | 0.07 CHF |
| Spread | 0.01 CHF |
| Spread % | 1.16% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
32.01
EUR
Average target price
26.74
EUR
Spread / Average Target
-16.48%
- Stock Market
- Warrants
- PPZZJB Warrant
